Inventor
DOPPALAPUDI VENKATA RAMANA
US45 patents
⚠️ This page may combine multiple inventors who share the name “DOPPALAPUDI VENKATA RAMANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVIDITY BIOSCIENCES INC
33 patentsUS10550188B2Feb 4, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC80 citations98
US11179472B2Nov 23, 2021
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
AVIDITY BIOSCIENCES INC35 citations97
US10994020B2May 4, 2021
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
AVIDITY BIOSCIENCES INC32 citations97
US10881743B2Jan 5, 2021
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC55 citations97
US12064483B2Aug 20, 2024
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
AVIDITY BIOSCIENCES INC19 citations94
US11400163B2Aug 2, 2022
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
AVIDITY BIOSCIENCES INC26 citations94
US11311627B1Apr 26, 2022
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
AVIDITY BIOSCIENCES INC28 citations94
US11110180B2Sep 7, 2021
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC19 citations93
US10787519B2Sep 29, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC19 citations93
US10487149B2Nov 26, 2019
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC21 citations93
US11028179B2Jun 8, 2021
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC16 citations92
US10913800B2Feb 9, 2021
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC19 citations92
US11576980B2Feb 14, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC6 citations85
US11446387B2Sep 20, 2022
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC8 citations85
US11253607B2Feb 22, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC7 citations85
US11246941B2Feb 15, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC7 citations85
US11554176B2Jan 17, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC2 citations84
US11497814B2Nov 15, 2022
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC3 citations84
US10800848B2Oct 13, 2020
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC7 citations83
US12427202B2Sep 30, 2025
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC1 citations74
US12006499B2Jun 11, 2024
Una amidites and uses thereof
AVIDITY BIOSCIENCES INC2 citations73
US11834510B2Dec 5, 2023
Anti-transferrin receptor antibodies and uses thereof
AVIDITY BIOSCIENCES INC4 citations73
US11583591B2Feb 21, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC2 citations73
US11707532B2Jul 25, 2023
Compositions and methods of treating muscle dystrophy
AVIDITY BIOSCIENCES INC3 citations72
US11364302B1Jun 21, 2022
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC2 citations71
US12365704B2Jul 22, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations62
US12351637B2Jul 8, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations62
US12234290B2Feb 25, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations62
US11712478B2Aug 1, 2023
Compositions and methods of treating muscle atrophy and myotonic dystrophy
AVIDITY BIOSCIENCES INC0 citations62
US11578090B2Feb 14, 2023
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC1 citations62
US12364769B2Jul 22, 2025
Nucleic acid-polypeptide compositions and uses thereof
AVIDITY BIOSCIENCES INC0 citations61
US12359202B2Jul 15, 2025
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
AVIDITY BIOSCIENCES INC1 citations58
US12071621B2Aug 27, 2024
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
AVIDITY BIOSCIENCES INC1 citations56
RES CORP TECHNOLOGIES INC
5 patentsUS6156745ADec 5, 2000
2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
RES CORP TECHNOLOGIES INC16 citations91
US6770759B2Aug 3, 2004
Penicillanic acid derivative compounds and methods of making
RES CORP TECHNOLOGIES INC7 citations72
US6436398B2Aug 20, 2002
2 β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
RES CORP TECHNOLOGIES INC1 citations61
US6906054B2Jun 14, 2005
Compositions for inhibiting beta-lactamase
RES CORP TECHNOLOGIES INC4 citations59
US6407091B1Jun 18, 2002
β-lactamase inhibiting compounds
RES CORP TECHNOLOGIES INC3 citations59